Camad, Saima M.
HRN: 23-19-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/07/2025
01/14/2025
IV
2.25g
Every 6 Hours
UTI Complicated
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes